Conference Coverage

OSA With Worsening Hypoxemia Raises Risk of Metabolic Syndrome

BALTIMORE—Patients with obstructive sleep apnea (OSA) who are prone to worsening of hypoxemia at night have a heightened...

• Read More

Conference Coverage

Slow-Wave Activity May Affect Depression

BALTIMORE—Disruption of slow-wave activity (SWA) may explain the positive influence that sleep deprivation appears to...

• Read More

Education Center

Neurology Board Review: Multiple Sclerosis

• Read More

Conference Coverage

Risk of ALS May Increase With Greater Exposure to Diesel Exhaust

LOS ANGELES —People with consistently high occupational exposures to diesel exhaust may have a higher risk of amyotrophic lateral sclerosis...

• Read More

Conference Coverage

Tasimelteon May Be Effective for Jet Lag Disorder

BALTIMORE—Tasimelteon, a drug approved for non–24-hour sleep-wake disorder, has been shown to increase sleep times in travelers with jet...

• Read More

Video

Deborah Friedman, MD, MPH

At the American Headache Society’s 60th Annual Scientific Meeting, Dr. Alan Rapoport speaks with Dr. Deborah Friedman about her Seymour Solomon...

• Read More

Video

Maria Eduarda Nobre, MD, PhD

Dr. Alan Rapoport interviews Dr. Maria Eduarda Nobre about clomiphene treatment for refractory episodic and chronic cluster headache.

• Read More

Video

Alan Rapoport, MD

At the American Headache Society’s 60th Annual Scientific Meeting, Dr. Alan Rapoport summarizes a poster he presented regarding ZOTRIP, Zosano...

• Read More

News

FDA Efforts to Advance Development of Gene Therapies

Once just a theory, gene therapies are now a therapeutic reality for some patients. These platforms may have the potential to treat and cure some...

• Read More

Conference Coverage

Droxidopa May Reduce Neurogenic Orthostatic Hypotension Symptoms in Patients Taking DDCIs

MIAMI—Droxidopa is associated with reductions in fall risk and dizziness or lightheadedness...

• Read More

Conference Coverage

Are Psychiatric Symptoms a Prodrome of Parkinson’s Disease?

MIAMI—Anxiety and depressive disorders may precede Parkinson’s disease diagnosis in more than...

• Read More

Conference Coverage

Ch4 Density Is a Potential Imaging Biomarker of Cognition in Early Parkinson’s Disease

MIAMI—Reduced cholinergic nucleus 4 (Ch4) density in Parkinson’s disease, as measured with MRI,...

• Read More

Conference Coverage

Sublingual Apomorphine Effectively Manages Off Episodes in Parkinson’s Disease

MIAMI—The sublingual apomorphine film APL-130277 (APL) is effective and well-tolerated for the...

• Read More

News Roundup

New and Noteworthy Information—July 2018

Short and long daily sleep duration are risk factors for dementia and death in adults age 60 and older, according to a study...

• Read More

Commentary

25+ Years of Migraine

Although migraine has been with humans since...

• Read More

Conference Coverage

Conference News Roundup—European Stroke Organization

Patients with intracerebral hemorrhage may benefit from receiving a drug currently used to treat blood loss from major trauma...

• Read More